Bleeding more than usual after a biopsy in the ankle; Infection in the site of the biopsy; Patient felt tired; Patient experienced a bit of sensitivity in his arm; This spontaneous case was reported by a consumer and describes the occurrence of SENSORY DISTURBANCE (Patient experienced a bit of sensitivity in his arm), POST PROCEDURAL HAEMORRHAGE (Bleeding more than usual after a biopsy in the ankle), LOCALISED INFECTION (Infection in the site of the biopsy) and FATIGUE (Patient felt tired) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A, 013L20A and 939903) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa), Sinusitis and Pre-diabetes (Start date: A couple of years ago.). Concomitant products included HYDROCHLOROTHIAZIDE for Diuretic therapy, BRIMONIDINE TARTRATE for Glaucoma, AMLODIPINE, ATORVASTATIN, LATANOPROST, VITAMINS NOS and CLOTRIMAZOLE for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced SENSORY DISTURBANCE (Patient experienced a bit of sensitivity in his arm) and FATIGUE (Patient felt tired). In October 2021, the patient experienced POST PROCEDURAL HAEMORRHAGE (Bleeding more than usual after a biopsy in the ankle) and LOCALISED INFECTION (Infection in the site of the biopsy). The patient was treated with AMOXICILLIN for Infection, at an unspecified dose and frequency; SILVER SULFADIAZINE for Wound, at an unspecified dose and frequency and CHLORHEXIDINE GLUCONATE (HIBICLENS) for Infection, at an unspecified dose and frequency. On 21-Feb-2021, SENSORY DISTURBANCE (Patient experienced a bit of sensitivity in his arm) had resolved with sequelae, FATIGUE (Patient felt tired) had resolved. In October 2021, POST PROCEDURAL HAEMORRHAGE (Bleeding more than usual after a biopsy in the ankle) and LOCALISED INFECTION (Infection in the site of the biopsy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, Blood test: results not provided Results not provided.         Patient experienced after 1st dose was already documented on previous case (MOD21-13133). After 2nd and booster shot, patient experienced a bit of sensitivity in his arm and he felt tired for about a couple of days.  Patient mentioned that on Oct2021 he visited his dermatologist to get a biopsy for Kaposi Sarcoma, and when doctor punctured his ankle with a needle, there was a bleeding more than usual, but doctor controlled it in that moment. Patient had to go back with the doctor 10 days later because of an infection in the site of the biopsy that lasted 3 weeks. Patient stated that on Jan2022 he made a regular blood test, but 1 or 2 days later he developed an unusual keloid scar or wound in the arm, in the site of needle puncturing to get the blood, it lasted 2 weeks. Doctor prescribed Amoxicillin and the antiseptic Hibiclens for his infection in the ankle, and treated his wound in the arm with Silver Sulfadiazine 1% cream.   This case was linked to MOD-2022-525975, MOD-2021-018091 (Patient Link).